Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Insulins | Research

Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study

Authors: Yang Cheng, Zhen Fang, Xinxin Zhang, Yuchen Wen, Jiaqi Lu, Shenghu He, Bing Xu

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

The triglyceride glucose-body mass index (TyG-BMI index) has been considered a reliable surrogate measure of insulin resistance; however, its ability to predict the incidence of cardiovascular disease in individuals with coronary artery disease (CAD) remains uncertain. The aim of this study was to demonstrate the correlation between the TyG-BMI index and cardiovascular incidence.

Methods

A total of 2533 consecutive participants who underwent percutaneous coronary intervention (PCI) and drug-eluting stent (DES) implantation were included. Data from 1438 patients was analyzed in the study. The endpoint was defined as a composite of acute myocardial infarction, repeat revascularization, stroke, and all-cause mortality (major adverse cardiac and cerebrovascular events, MACCEs) at 34-month follow-up. The formula for calculating the TyG-BMI index is ln [fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2] × BMI.

Results

Among the 1438 participants, 195 incident patient cases of MACCEs were ascertained. The incidence of MACCEs showed no statistically significant differences in the TyG-BMI index tertiles in the overall population. Further exploratory subgroup analysis and multivariable logistic regression analysis revealed a linear relationship between the TyG-BMI index (per 1 SD increased) and MACCEs in the elderly patients (OR = 1.22, 95% CI 1.011–1.467, p = 0.038) and in the female patients (OR = 1.33, 95% CI 1.004–1.764, p = 0.047). The addition of the TyG-BMI index to traditional risk factor models in elderly and female patients did not improve risk prediction for MACCEs.

Conclusion

A higher TyG-BMI index was proportionally related to an increased incidence of MACCEs in the elderly or female patients. However, the inclusion of the TyG-BMI index did not provide better predictive performance for MACCEs in the elderly, specifically in female patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71.CrossRefPubMed Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71.CrossRefPubMed
2.
go back to reference The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci. 2022;35(7):573–603. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci. 2022;35(7):573–603.
3.
go back to reference Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.PubMedCentralCrossRefPubMed Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.PubMedCentralCrossRefPubMed
4.
go back to reference Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao X-Q, Li W, Li H. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43.PubMedCentralCrossRefPubMed Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao X-Q, Li W, Li H. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43.PubMedCentralCrossRefPubMed
5.
6.
go back to reference Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean national health and nutrition examination survey. PLoS ONE. 2019;14(3): e0212963.PubMedCentralCrossRefPubMed Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean national health and nutrition examination survey. PLoS ONE. 2019;14(3): e0212963.PubMedCentralCrossRefPubMed
7.
go back to reference Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.PubMedCentralCrossRefPubMed Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.PubMedCentralCrossRefPubMed
8.
go back to reference Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. The impact of the triglyceride-glucose index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021;12: 710240.CrossRef Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. The impact of the triglyceride-glucose index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021;12: 710240.CrossRef
9.
go back to reference Kim J, Shin SJ, Kang HT. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: a retrospective study based on the NHIS-HEALS cohort. PLoS ONE. 2021;16(11): e0259212.PubMedCentralCrossRefPubMed Kim J, Shin SJ, Kang HT. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: a retrospective study based on the NHIS-HEALS cohort. PLoS ONE. 2021;16(11): e0259212.PubMedCentralCrossRefPubMed
10.
go back to reference Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.PubMedCentralCrossRefPubMed Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.PubMedCentralCrossRefPubMed
11.
go back to reference Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed
12.
go back to reference Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.CrossRefPubMed Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.CrossRefPubMed
13.
14.
go back to reference Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19(1):155.PubMedCentralCrossRefPubMed Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19(1):155.PubMedCentralCrossRefPubMed
15.
go back to reference Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, Wang Y. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.PubMedCentralCrossRefPubMed Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, Wang Y. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.PubMedCentralCrossRefPubMed
16.
go back to reference Zhang Y, Ren L, Ren M, Yang H, Li K, Cong H, Guo Z. Correlation between the triglyceride-glucose index and high risk of cardiovascular disease: a cohort study of 102,061 subjects from Tianjin, China. Risk Manag Healthc Policy. 2021;14:2803–10.PubMedCentralCrossRefPubMed Zhang Y, Ren L, Ren M, Yang H, Li K, Cong H, Guo Z. Correlation between the triglyceride-glucose index and high risk of cardiovascular disease: a cohort study of 102,061 subjects from Tianjin, China. Risk Manag Healthc Policy. 2021;14:2803–10.PubMedCentralCrossRefPubMed
17.
go back to reference Özkalaycı F, Karagöz A, Karabay CY, Tanboga İH, Türkyılmaz E, Saygı M, Oduncu V. Prognostic value of triglyceride/glucose index in patients with ST-segment elevation myocardial infarction. Biomark Med. 2022;16(8):613–22.CrossRefPubMed Özkalaycı F, Karagöz A, Karabay CY, Tanboga İH, Türkyılmaz E, Saygı M, Oduncu V. Prognostic value of triglyceride/glucose index in patients with ST-segment elevation myocardial infarction. Biomark Med. 2022;16(8):613–22.CrossRefPubMed
19.
go back to reference Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17(1):268.PubMedCentralCrossRefPubMed Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17(1):268.PubMedCentralCrossRefPubMed
20.
go back to reference Won KB, Park EJ, Han D, Lee JH, Choi SY, Chun EJ, Park SH, Han HW, Sung J, Jung HO, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):34.PubMedCentralCrossRefPubMed Won KB, Park EJ, Han D, Lee JH, Choi SY, Chun EJ, Park SH, Han HW, Sung J, Jung HO, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):34.PubMedCentralCrossRefPubMed
22.
go back to reference Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride Glucose-Body Mass Index Is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3): e0149731.PubMedCentralCrossRefPubMed Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride Glucose-Body Mass Index Is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3): e0149731.PubMedCentralCrossRefPubMed
23.
go back to reference Du Z, Xing L, Lin M, Sun Y. Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population. BMC Cardiovasc Disord. 2020;20(1):483.PubMedCentralCrossRefPubMed Du Z, Xing L, Lin M, Sun Y. Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population. BMC Cardiovasc Disord. 2020;20(1):483.PubMedCentralCrossRefPubMed
24.
go back to reference Yao HM, Wan YD, Zhang XJ, Shen DL, Zhang JY, Li L, Zhao LS, Sun TW. Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre. BMJ Open. 2014;4(8): e004892.PubMedCentralCrossRefPubMed Yao HM, Wan YD, Zhang XJ, Shen DL, Zhang JY, Li L, Zhao LS, Sun TW. Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre. BMJ Open. 2014;4(8): e004892.PubMedCentralCrossRefPubMed
25.
26.
go back to reference Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters G, Mahanani WR, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54.CrossRefPubMed Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters G, Mahanani WR, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54.CrossRefPubMed
27.
go back to reference Tello-Flores VA, Beltrán-Anaya FO, Ramírez-Vargas MA, Esteban-Casales BE, Navarro-Tito N, Alarcón-Romero LDC, Luciano-Villa CA, Ramírez M, Del Moral-Hernández Ó, Flores-Alfaro E. Role of long non-coding RNAs and the molecular mechanisms involved in insulin resistance. Int J Mol Sci. 2021;22(14):7256.PubMedCentralCrossRefPubMed Tello-Flores VA, Beltrán-Anaya FO, Ramírez-Vargas MA, Esteban-Casales BE, Navarro-Tito N, Alarcón-Romero LDC, Luciano-Villa CA, Ramírez M, Del Moral-Hernández Ó, Flores-Alfaro E. Role of long non-coding RNAs and the molecular mechanisms involved in insulin resistance. Int J Mol Sci. 2021;22(14):7256.PubMedCentralCrossRefPubMed
28.
go back to reference Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.CrossRefPubMed Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.CrossRefPubMed
29.
go back to reference Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M. The association between six surrogate insulin resistance indexes and hypertension: a population-based study. Metab Syndr Relat Disord. 2019;17(6):328–33.CrossRefPubMed Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M. The association between six surrogate insulin resistance indexes and hypertension: a population-based study. Metab Syndr Relat Disord. 2019;17(6):328–33.CrossRefPubMed
30.
go back to reference Gu Q, Hu X, Meng J, Ge J, Wang SJ, Liu XZ. Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk: a cohort study in chinese general population. Int J Endocrinol. 2020;2020:3214716.PubMedCentralCrossRefPubMed Gu Q, Hu X, Meng J, Ge J, Wang SJ, Liu XZ. Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk: a cohort study in chinese general population. Int J Endocrinol. 2020;2020:3214716.PubMedCentralCrossRefPubMed
31.
go back to reference Han R, Zhang Y, Jiang X. Relationship between four non-insulin-based indexes of insulin resistance and serum uric acid in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:1461–71.PubMedCentralCrossRefPubMed Han R, Zhang Y, Jiang X. Relationship between four non-insulin-based indexes of insulin resistance and serum uric acid in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:1461–71.PubMedCentralCrossRefPubMed
32.
go back to reference Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, Zheng L. Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021;12(11):2046–53.PubMedCentralCrossRefPubMed Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, Zheng L. Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021;12(11):2046–53.PubMedCentralCrossRefPubMed
33.
go back to reference Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.PubMedCentralCrossRefPubMed Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.PubMedCentralCrossRefPubMed
34.
go back to reference Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351–62.CrossRefPubMed Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351–62.CrossRefPubMed
35.
go back to reference Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31.PubMedCentralCrossRefPubMed Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31.PubMedCentralCrossRefPubMed
36.
go back to reference Wada H, Miyauchi K, Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther. 2019;17(2):127–33.CrossRefPubMed Wada H, Miyauchi K, Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther. 2019;17(2):127–33.CrossRefPubMed
38.
go back to reference Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, Wang A. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19.PubMedCentralCrossRefPubMed Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, Wang A. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19.PubMedCentralCrossRefPubMed
39.
go back to reference Nakagomi A, Sunami Y, Kawasaki Y, Fujisawa T, Kobayashi Y. Sex difference in the association between surrogate markers of insulin resistance and arterial stiffness. J Diabetes Complications. 2020;34(6): 107442.CrossRefPubMed Nakagomi A, Sunami Y, Kawasaki Y, Fujisawa T, Kobayashi Y. Sex difference in the association between surrogate markers of insulin resistance and arterial stiffness. J Diabetes Complications. 2020;34(6): 107442.CrossRefPubMed
40.
go back to reference Capranzano P, Angiolillo DJ. Antithrombotic management of elderly patients with coronary artery disease. JACC Cardiovasc Interv. 2021;14(7):723–38.CrossRefPubMed Capranzano P, Angiolillo DJ. Antithrombotic management of elderly patients with coronary artery disease. JACC Cardiovasc Interv. 2021;14(7):723–38.CrossRefPubMed
41.
go back to reference Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010;303(18):1841–7.CrossRefPubMed Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010;303(18):1841–7.CrossRefPubMed
42.
43.
go back to reference Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.CrossRefPubMed Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.CrossRefPubMed
44.
go back to reference Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487–95.PubMedCentralCrossRefPubMed Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487–95.PubMedCentralCrossRefPubMed
45.
46.
go back to reference Wu Z, Liu L, Wang W, Cui H, Zhang Y, Xu J, Zhang W, Zheng T, Yang J. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.PubMedCentralCrossRefPubMed Wu Z, Liu L, Wang W, Cui H, Zhang Y, Xu J, Zhang W, Zheng T, Yang J. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.PubMedCentralCrossRefPubMed
47.
go back to reference Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949–58.CrossRefPubMed Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949–58.CrossRefPubMed
48.
go back to reference The Lancet Diabetes. Menopause: a turning point for women’s health. Lancet Diabetes Endocrinol. 2022;10(6):373.CrossRef The Lancet Diabetes. Menopause: a turning point for women’s health. Lancet Diabetes Endocrinol. 2022;10(6):373.CrossRef
Metadata
Title
Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study
Authors
Yang Cheng
Zhen Fang
Xinxin Zhang
Yuchen Wen
Jiaqi Lu
Shenghu He
Bing Xu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-01794-8

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine